You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
宏利延續「接種疫苗副作用免費保障」 累批近800宗新冠相關索償
阿思達克 01-10 11:27
宏利宣佈延續自去年1月起推出的「接種疫苗副作用免費保障」措施至今年6月30日。自新冠肺炎疫情爆發以來,先後爲客戶提供不同額外保障,至今處理並批出接近800宗與新冠肺炎相關的索償申請。 宏利「接種疫苗副作用免費保障」包括如受保客戶在接種疫苗後出現不良反應,於香港或澳門以門診方式諮詢註冊醫生,並於隨後的14日內住院且獲以下住院現金保障,將可獲得300元的住院前門診現金保障(最多1次);將獲得每日800元的住院現金保障,長達14日(只限1次住院);如受保客戶在接種疫苗出現不良反應後30日內,不幸因不良反應或其併發症於香港或澳門身故,將獲得20萬元的恩恤身故保障。
Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account